Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q1 2024 · 10-Q
Revenue$7.64M$7.64M+40.6% vs Q1 2023 Net Income-$4.15M-$4.15MN/M vs Q1 2023 EPS Diluted-$0.16-$0.16N/M vs Q1 2023 Gross Profit$4,525,000+41.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flow-$3,840,000N/M Free Cash Flowderived-$3,840,000N/M Margins · derivedGross margin59.2%+0.3 pt vs Q1 2023
Operating margin-55.2%+49.9 pt vs Q1 2023
Net margin-54.3%+49.0 pt vs Q1 2023
ended Mar 31, 2024 · filed May 7, 2024 · 37 d after period end